Related Experiment Videos
Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA
Michael T Barrett1, Alicia Scheffer, Amir Ben-Dor
1Agilent Technologies, 3500 Deer Creek Road, Palo Alto, CA 94304, USA.
Summary
This study introduces novel oligonucleotide microarrays for array-based comparative genomic hybridization (CGH), offering a robust platform for detecting genomic copy-number variations. These arrays provide precise and sensitive detection of chromosomal alterations using total genomic DNA.
Area of Science:
- Genomics
- Molecular Biology
- Biotechnology
Background:
- Array-based comparative genomic hybridization (CGH) is crucial for identifying copy-number variations in diseases.
- Traditional CGH arrays using BAC or cDNA clones face challenges in maintenance, propagation, and hybridization specificity.
- Developing a more robust and flexible CGH platform is essential for advancing genomic research and diagnostics.
Purpose of the Study:
- To develop and validate oligonucleotide microarrays synthesized in situ for array-based CGH applications.
- To create a more robust, flexible, and specific platform for detecting genomic copy-number variations.
- To demonstrate the utility of oligonucleotide arrays for analyzing total genomic DNA.
Main Methods:
- Designed and synthesized oligonucleotide microarrays using inkjet technology for CGH.
- Developed probe-design methods and assay protocols for compatibility with total genomic DNA.
- Validated array performance using cell lines with varying X chromosome numbers and model systems with known chromosomal alterations.
Main Results:
- Oligonucleotide arrays achieved high accuracy in measuring copy-number variations, with median ratios close to theoretical values for X chromosome probes.
- The arrays successfully detected and mapped single-copy losses, homozygous deletions, and amplicons in various model systems.
- Demonstrated high sensitivity in detecting chromosomal alterations throughout the genome using full-complexity genomic samples.
Conclusions:
- Oligonucleotide microarrays offer a robust and precise platform for array-based CGH.
- This technology enables sensitive detection of chromosomal alterations with high accuracy, even with total genomic DNA.
- The developed platform has significant potential for cancer research, developmental disorder studies, and diagnostic target development.